Encellin

San Francisco, United States

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

$9.9M raised

Dec 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Encellin raised?

Encellin has raised $9.9M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are Encellin's investors?

Encellin's investors include Y Combinator, Khosla Ventures, Endurance28, Sand Hill Angels, Formic Ventures.

Where is Encellin headquartered?

Encellin is headquartered in San Francisco, United States.

What does Encellin do?

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

What stage is Encellin at?

Encellin is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 13, 2023.

MLA

"Encellin — Funding & Investors." VCBacked, December 13, 2023, https://www.vcbacked.co/company/encellin. Accessed July 11, 2026.

APA

VCBacked. (2023). Encellin — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/encellin

Wikipedia (cite web)

{{cite web |title=Encellin — Funding & Investors |url=https://www.vcbacked.co/company/encellin |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 13, 2023.